ABT-414
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ABT-414, covering 2017-11-20 to 2023-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification [Phase 3]